A prevalent CTLA4 missense variant significantly associates with inhibitor development in Argentine patients with severe haemophilia A

被引：5
作者：
Marchione, V. D. [1 ]
Zuccoli, J. R. [2 ]
Abelleyro, M. M. [1 ]
Radic, C. P. [1 ]
Neme, D. [3 ]
Candela, M. [4 ]
de Tezanos Pinto, M. [3 ,4 ]
De Brasi, C. D. [1 ,4 ]
Rossetti, L. C. [1 ]
机构：
[1] Acad Nacl Med Buenos Aires, CONICET, Inst Med Expt IMEX, Buenos Aires, DF, Argentina
[2] CIPYP, Buenos Aires, DF, Argentina
[3] Fdn Hemofilia Alfredo Pavlovsky, Buenos Aires, DF, Argentina
[4] Acad Nacl Med Buenos Aires, Inst Invest Hematol Mariano R Castex, Buenos Aires, DF, Argentina
来源：
HAEMOPHILIA | 2017年 / 23卷 / 02期
关键词：
GENE; POLYMORPHISMS;
D O I：
10.1111/hae.13194
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E166 / E169
页数：4
相关论文
共 16 条
  • [1] A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele
    Anjos, S
    Nguyen, A
    Ounissi-Benkalha, H
    Tessier, MC
    Polychronakos, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (48) : 46478 - 46486
  • [2] Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A
    Astermark, J.
    Wang, X.
    Oldenburg, J.
    Berntorp, E.
    Lefvert, A. -K.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (02) : 263 - 265
  • [3] FVIII inhibitors: pathogenesis and avoidance
    Astermark, Jan
    [J]. BLOOD, 2015, 125 (13) : 2045 - 2051
  • [4] The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort
    Astermark, Jan
    Donfield, Sharyne M.
    Gomperts, Edward D.
    Schwarz, John
    Menius, Erika D.
    Pavlova, Anna
    Oldenburg, Johannes
    Kessing, Bailey
    DiMichele, Donna M.
    Shapiro, Amy D.
    Winkler, Cheryl A.
    Berntorp, Erik
    [J]. BLOOD, 2013, 121 (08) : 1446 - 1454
  • [5] Cytotoxic T lymphocyte antigen 4 heterozygous codon 49 A/G dimorphism is associated to latent autoimmune diabetes in adults (LADA)
    Caputo, M
    Cerrone, GE
    López, AP
    Villalba, A
    Krochik, GA
    Cédola, FN
    Targovnik, HM
    Frechtel, GD
    [J]. AUTOIMMUNITY, 2005, 38 (04) : 277 - 281
  • [6] An Mse I RFLP in the human CTLA4 promotor
    Deichmann, K
    Heinzmann, A
    Bruggenolte, E
    Forster, J
    Kuehr, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 225 (03) : 817 - 818
  • [7] F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis
    Gouw, Samantha C.
    van den Berg, H. Marijke
    Oldenburg, Johannes
    Astermark, Jan
    de Groot, Philip G.
    Margaglione, Maurizio
    Thompson, Arthur R.
    van Heerde, Waander
    Boekhorst, Jorien
    Miller, Connie H.
    le Cessie, Saskia
    van der Bom, Johanna G.
    [J]. BLOOD, 2012, 119 (12) : 2922 - 2934
  • [8] CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease
    Kacem, HH
    Bellassoued, M
    Bougacha-Elleuch, N
    Abid, M
    Ayadi, H
    [J]. CLINICAL IMMUNOLOGY, 2001, 101 (03) : 361 - 365
  • [9] Factor VIII genotype characterization of haemophilia A affected patients with transient and permanent inhibitors: a comprehensive Argentine study of inhibitor risks
    Rossetti, L. C.
    Szurkalo, I.
    Radic, C. P.
    Abelleyro, M. M.
    Primiani, L.
    Neme, D.
    Candela, M.
    Bianco, R. P.
    de Tezanos Pinto, M.
    Larripa, I. B.
    De Brasi, C. D.
    [J]. HAEMOPHILIA, 2013, 19 (04) : 511 - 518
  • [10] Sixteen novel hemophilia A causative mutations in the first Argentinian series of severe molecular defects
    Rossetti, Liliana C.
    Pamela Radic, Claudia
    Candela, Miguel
    Perez Bianco, Raul
    de Tezanos Pinto, Miguel
    Goodeve, Anne
    Larripa, Irene B.
    De Brasi, Carlos D.
    [J]. HAEMATOLOGICA, 2007, 92 (06) : 842 - 845
12